The Royal Marsden NHS Foundation Trust
Demystifying the science behind targeted treatments and immunotherapies for malignant melanoma.
This study day is aimed at Allied Healthcare Professionals, doctors and nurses.
Date: 04 July 2022
Time: 10:00 until
13:00
Length: 1 day
Venue: Virtual
Over the course of one morning Dr Elaine Vickers provides an up-to-date overview of the science behind targeted treatments and immunotherapies for people with malignant melanoma.
Elaine begins with the gene mutations that cause melanoma and describes the biology of this disease and its relationship with the immune system. She then describes various treatment approaches, such as B-Raf and MEK inhibitors and immunotherapy with checkpoint inhibitors.
Programme sessions, themes and workshops
Fees:
£50 per delegate
Contact Information:
For further information, application, registration and booking forms, please apply to the event organiser:Name: Conference Team
Address:
Tel: 020 7808 2921
Email: conferenceteam@rmh.nhs.uk
Website: https://www.royalmarsden.nhs.uk/demystifying-science-behind-targeted-treatments-and-immunotherapies-malignant-melanoma-and-bowel
Submitted by The Royal Marsden Conference Team on Tuesday, 15 February, 2022 11:02:55 GMT
